BioNexus Gene Lab Corp. (BGLC)

1.55 +3.33% (+0.05)

Over 6M: -43.1%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1.5 2 2.5
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 3.6M Q3 '21 — Operating Cash Flow: 315.9K Q3 '21 — Free Cash Flow: 315.5K Q4 '21 — Revenue: 3.2M Q4 '21 — Operating Cash Flow: 483K Q4 '21 — Free Cash Flow: 481.7K Q1 '22 — Revenue: 3M Q1 '22 — Operating Cash Flow: -37.8K Q1 '22 — Free Cash Flow: -70K Q2 '22 — Revenue: 2.5M Q2 '22 — Operating Cash Flow: -196K Q2 '22 — Free Cash Flow: -197.3K Q3 '22 — Revenue: 2.6M Q3 '22 — Operating Cash Flow: 308.9K Q3 '22 — Free Cash Flow: 305.2K Q4 '22 — Revenue: 2.8M Q4 '22 — Operating Cash Flow: 476.7K Q1 '23 — Revenue: 2.4M Q1 '23 — Operating Cash Flow: -116.5K Q1 '23 — Free Cash Flow: -116.6K Q2 '23 — Revenue: 2.6M Q2 '23 — Operating Cash Flow: -23.8K Q2 '23 — Free Cash Flow: -38.2K Q3 '23 — Revenue: 2.6M Q3 '23 — Operating Cash Flow: -899.3K Q3 '23 — Free Cash Flow: -1M Q4 '23 — Revenue: 2.3M Q4 '23 — Operating Cash Flow: -782.5K Q4 '23 — Free Cash Flow: -783.5K Q1 '24 — Revenue: 2.4M Q1 '24 — Operating Cash Flow: -37.2K Q1 '24 — Free Cash Flow: -59.1K Q2 '24 — Revenue: 2M Q2 '24 — Operating Cash Flow: -672.3K Q2 '24 — Free Cash Flow: -674.1K Q3 '24 — Revenue: 2.6M Q3 '24 — Operating Cash Flow: -1.6M Q3 '24 — Free Cash Flow: -1.8M Q4 '24 — Revenue: 2.5M Q4 '24 — Operating Cash Flow: 219.2K Q4 '24 — Free Cash Flow: 215.2K Q1 '25 — Revenue: 2.1M Q1 '25 — Operating Cash Flow: -824.1K Q1 '25 — Free Cash Flow: -833.1K Q2 '25 — Revenue: 2.3M Q2 '25 — Operating Cash Flow: -737.9K Q2 '25 — Free Cash Flow: -759.4K Q3 '25 — Revenue: 2.5M Q3 '25 — Operating Cash Flow: -1.2M Q3 '25 — Free Cash Flow: -1.2M Q4 '25 — Revenue: 483.8K Q4 '25 — Operating Cash Flow: 961.1K Q4 '25 — Free Cash Flow: 960.1K Q1 '26 — Revenue: 22.8K Q1 '26 — Operating Cash Flow: -147.7K Q1 '26 — Free Cash Flow: -148K Q2 '26 — Revenue: 76.2K Q2 '26 — Operating Cash Flow: -422.5K Q2 '26 — Free Cash Flow: -422.7K -1.5M 0 1.5M 3M 4.5M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 25.4%
OE margin -52.7%
Oper. margin -81.8%
ROIC -30.6%
Accruals -19.8%
EBITDA margin -78.2%
FCF margin -27.3%
Gross margin 12.3%
OCF margin -27.1%
Profit margin -82.4%
ROA -29.5%
ROCE -32.3%
ROE -33.1%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.9
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -560.9×
Cash / Debt 23.5×
Debt / Eq 0.0068×
Debt payback 0.0 yr
Quick ratio 5.3×
Cash runway 1.4 yr
F-score 3.4 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.6
Sales CAGR 4Y -13.7%
Sales/sh Y/Y -67.3%
Sales Q/Q -96.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Shares change —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.